Problems paying for prescription drugs Source: Montero, et al KFF, November 14, 2025 Implications for employers: Plan member interest in GLP-1 medications to treat obesity and cardiometabolic disease is likely to continue to increase
[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Xuan Y, Yang Y, Xiang L, Zhang C
Safety summary with warnings Warnings - Zepbound may cause tumors in the thyroid, including thyroid cancer
Whether youre starting on semaglutide, considering microdosing, or planning a long-term regimen, understanding the dosing strategies is key to maximizing its benefits while minimizing side effects
The effect of concentration of oleate on metabolism of triglycerides and on ketogenesis
A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study